Anticholinergics May Carry Significant Cognitive and Gait Burden in Parkinson's Disease.
Roopa RajanArti SainiBhawna VermaNishu ChoudharyAnu GuptaVenugopalan Yamuna VishnuRohit BhatiaMamta B SinghAchal K SrivastavaMadakasira Vasantha Padma SrivastavaPublished in: Movement disorders clinical practice (2020)
Patients with PD are exposed to significant anticholinergic burden from drugs prescribed for PD and non-PD indications. Higher anticholinergic burden is associated with cognitive impairment and FOG even in younger patients with PD.
Keyphrases